Vanguard Personalized Indexing Management’s BridgeBio Pharma BBIO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $699K | Buy |
16,178
+772
| +5% | +$33.3K | 0.01% | 1050 |
|
|
2025
Q1 | $533K | Buy |
15,406
+677
| +5% | +$23.4K | 0.01% | 1082 |
|
|
2024
Q4 | $404K | Buy |
14,729
+2,604
| +21% | +$71.5K | 0.01% | 1211 |
|
|
2024
Q3 | $309K | Buy |
12,125
+1,923
| +19% | +$49K | 0.01% | 1332 |
|
|
2024
Q2 | $258K | Buy |
10,202
+1,617
| +19% | +$41K | ﹤0.01% | 1335 |
|
|
2024
Q1 | $265K | Buy |
8,585
+1,156
| +16% | +$35.7K | 0.01% | 1323 |
|
|
2023
Q4 | $300K | Buy |
+7,429
| New | +$300K | 0.01% | 1223 |
|
|
2021
Q3 | – | Sell |
-4,235
| Closed | -$258K | – | 983 |
|
|
2021
Q2 | $258K | Buy |
+4,235
| New | +$258K | 0.03% | 793 |
|